Signalling and production in the endocannabinoid system 

Signalling and production in the endocannabinoid system 
The cannabinoid system is implicated in many physiological functions of the human body. Cannabinoid receptors present a promising therapeutic target for a number of conditions, including psychological and movement disorders, obesity, neuropathic pain and cancer.
 
Cannabinoid receptors (CB1and CB2) are involved in many physiological 
processes. Located in the cell membrane, these receptors can be 
activated by endocannabinoids (produced by the body), as well as plant 
or synthetic cannabinoids. The endocannabinoid system can be regulated 
by several pathways. One involves a protein, beta-arrestin which dampens
 cellular response to a variety of stimuli. However, the details of 
these interactions are unknown.
The project ' CB1R ARRESTIN  is unravelling the mechanisms of 
cannabinoid regulation. In the course of the project, two CB2 receptor 
mutants were studied. One mutation is overrepresented in patients with 
major depression, alcoholism, and autoimmune disorders, while the other 
is associated with bipolar disorder.
The study of mutant receptors in vitro for binding with 
beta-arrestin, revealed that both were different to the binding in the 
wild-type receptor. After confirming the specificity of binding, , the 
researchers overexpressed CB2 receptor in a cell line and isolated 
interacting protein candidates . Mass spectrometry identified the 
interacting partners of the wild-type CB2 and the mutant receptors. Over
 2 000 interacting proteins binding CB2 were identified, with a few 
dozen of differences between mutants.  CB1R ARRESTIN  research analysed 
the functions of several of these proteins.
In addition, novel approaches studied the expression of CB2 in 
neuronal cells and its participation in the regulation of the neuronal 
functions. A cell-specific method of protein purification was developed,
 allowing for in vitro separation of the proteins with different 
cell-origin even if the cell lysates were mixed. Obtaining protein 
expression profiles of specific cells instead of cell mixtures in 
tissues can lead to discovery of novel therapeutic targets in the 
future.
Taking part in so many physiological processes, the pharmacalogical 
manipulation of the endocannabinoid system has great potential in a 
large number of diseases and conditions.
published: 2015-03-16